
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
Selected Abstracts
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadealmost 28 years ago
New Drug Class Offers Benefits in Heart Failurealmost 28 years ago
What are the Pharmacological Differences Between Angiotensin II Antagonistsalmost 28 years ago
Clinical Implications of Differences Between Angiotensin II AntagonistsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
3
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
4
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
5





